CIPH β€” Ciphergen Biosystems COM ciph equity

Ownership history in ORBIMED CAPITAL LLC  Β·  1 quarter on record

This page tracks every 13F SEC filing in which ORBIMED CAPITAL LLC reported a position in Ciphergen Biosystems COM ciph equity (CIPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
1.01% (2002 Q4)
πŸ“Š Avg. % of fund
1.01%
πŸ“… First filed
2002 Q4
πŸ“… Last filed
2002 Q4
⏱ Quarters held
1
% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2002 Q4 INITIATED 600,000 β€” β€” 1.01% $2.1M β€”

🏒 Other funds also holding CIPH

As of 2007 Q2 β€” sorted by position size

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI 3Y 7Y 0.03% VANGUARD GROUP INC 3Y 7Y 0.0% FEDERATED HERMES, INC. 3Y 7Y 0.0% WELCH & FORBES LLC 3Y 7Y 0.0% WELLINGTON MANAGEMENT GROUP LLP 3Y 7Y 0.0% DIMENSIONAL FUND ADVISORS LP 3Y 7Y 0.0% D. E. Shaw & Co., Inc. 3Y 7Y 0.0% RBC Capital Markets, LLC 3Y 7Y 0.0% BARCLAYS PLC 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0%
← Back to ORBIMED CAPITAL LLC Holdings